FDA Approves Takeda’s EoE Therapy EOHILIA
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
- Latest
- Trending
FDA approves Takeda's EOHILIA as first-line treatment for Eosinophilic Esophagitis. Groundbreaking oral therapy offers hope for improved quality of life.
Novo Nordisk sees massive sales jump and expects further growth in 2024, driven by the demand for its diabetes and ...
"Explore the immersive and treacherous world of post-apocalyptic Moscow in Metro Awakening, a VR prequel to the iconic Metro series. ...
Prepare for heavy snowfall and dangerous travel conditions as a Winter Storm Warning is in effect for the White Mountains ...
Discover the promising future for investors in Eli Lilly and Company (NYSE: LLY), a leader in the biopharmaceutical industry, with ...
Virtual reality-based meditation is offering new hope to Veterans with treatment-resistant depression by providing an immersive and transformative experience. #MentalHealthCare ...
Teva completes enrollment for Phase 3 trial of mdc-TJK, a potential treatment for schizophrenia. Results expected in 2024. #schizophrenia #clinicaltrials
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.